Interferon-alpha and cytosine arabinoside therapy in chronic myeloid leukemia.
Ezaki
K
K
Department of Internal Medicine, Fujita Health University School of Medicine, Aichi, Japan.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003561:Cytarabine / Q000008:administration & dosage* / Q000627:therapeutic use; D006801:Humans; D016898:Interferon-alpha / Q000008:administration & dosage* / Q000627:therapeutic use; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy*; D015466:Leukemia, Myeloid, Chronic-Phase / Q000188:drug therapy; D016032:Randomized Controlled Trials as Topic; D016019:Survival Analysis
D016898:Interferon-alpha; D003561:Cytarabine